In fact, tau is an independent prognostic marker in prostate cancer and tau expression was increased in metastatic tissue compared with primary breast cancer cells (Schroeder et al. 2019; Matrone et al. 2010). This evidence concerns the gene MAPT and prostate carcinoma.